APA
Fennell B. J., McDonnell B., Tam A. S. P., Chang L., Steven J., Broadbent I. D., Gao H., Kieras E., Alley J., Luxenberg D., Edmonds J., Fitz L. J., Miao W., Whitters M. J., Medley Q. G., Guo Y. J., Darmanin-Sheehan A., Autin B., Shúilleabháin D. N., Cummins E., King A., Krebs M. R. H., Grace C., Hickling T. P., Boisvert A., Zhong X., McKenna M., Francis C., Olland S., Bloom L., Paulsen J., Somers W., Jensen A., Lin L., Finlay W. J. J. & Cunningham O. (20150113). CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery. : mAbs.
Chicago
Fennell Brian J, McDonnell Barry, Tam Amy Sze Pui, Chang Lijun, Steven John, Broadbent Ian D, Gao Huilan, Kieras Elizabeth, Alley Jennifer, Luxenberg Deborah, Edmonds Jason, Fitz Lori J, Miao Wenyan, Whitters Matthew J, Medley Quintus G, Guo Yongjing J, Darmanin-Sheehan Alfredo, Autin Bénédicte, Shúilleabháin Deirdre Ní, Cummins Emma, King Amy, Krebs Mark R H, Grace Christopher, Hickling Timothy P, Boisvert Angela, Zhong Xiaotian, McKenna Matthew, Francis Christopher, Olland Stephane, Bloom Laird, Paulsen Janet, Somers Will, Jensen Allan, Lin Laura, Finlay William J J and Cunningham Orla. 20150113. CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery. : mAbs.
Harvard
Fennell B. J., McDonnell B., Tam A. S. P., Chang L., Steven J., Broadbent I. D., Gao H., Kieras E., Alley J., Luxenberg D., Edmonds J., Fitz L. J., Miao W., Whitters M. J., Medley Q. G., Guo Y. J., Darmanin-Sheehan A., Autin B., Shúilleabháin D. N., Cummins E., King A., Krebs M. R. H., Grace C., Hickling T. P., Boisvert A., Zhong X., McKenna M., Francis C., Olland S., Bloom L., Paulsen J., Somers W., Jensen A., Lin L., Finlay W. J. J. and Cunningham O. (20150113). CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery. : mAbs.
MLA
Fennell Brian J, McDonnell Barry, Tam Amy Sze Pui, Chang Lijun, Steven John, Broadbent Ian D, Gao Huilan, Kieras Elizabeth, Alley Jennifer, Luxenberg Deborah, Edmonds Jason, Fitz Lori J, Miao Wenyan, Whitters Matthew J, Medley Quintus G, Guo Yongjing J, Darmanin-Sheehan Alfredo, Autin Bénédicte, Shúilleabháin Deirdre Ní, Cummins Emma, King Amy, Krebs Mark R H, Grace Christopher, Hickling Timothy P, Boisvert Angela, Zhong Xiaotian, McKenna Matthew, Francis Christopher, Olland Stephane, Bloom Laird, Paulsen Janet, Somers Will, Jensen Allan, Lin Laura, Finlay William J J and Cunningham Orla. CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery. : mAbs. 20150113.